Cao, Zhiying http://orcid.org/0009-0007-6927-8907
Han, Kaiyue http://orcid.org/0009-0009-1090-199X
Lu, Hanting
Illangamudalige, Sandalika
Shaheed, Christina Abdel http://orcid.org/0000-0003-1258-5125
Chen, Lingxiao http://orcid.org/0000-0001-7721-0493
McLachlan, Andrew J. http://orcid.org/0000-0003-4674-0242
Patanwala, Asad E. http://orcid.org/0000-0003-3999-4703
Maher, Christopher G. http://orcid.org/0000-0002-1628-7857
Lin, Chung-Wei Christine http://orcid.org/0000-0001-6192-7238
March, Lyn http://orcid.org/0000-0003-1736-8111
Ferreira, Manuela L. http://orcid.org/0000-0002-3479-0683
Mathieson, Stephanie http://orcid.org/0000-0002-7335-8842
Funding for this research was provided by:
Open Access funding enabled and organized by CAUL and its Member Institutions
University of Sydney
Article History
Accepted: 6 June 2024
First Online: 28 June 2024
Declarations
:
: Open Access funding enabled and organized by CAUL and its Member Institutions.
: Zhiying Cao, Kaiyue Han, Hanting Lu, Sandalika Illangamudalige, Christina Abdel Shaheed, Lingxiao Chen, Asad E Patanwala, Christopher G Maher, Chung-Wei Christine Lin, Lyn March and Stephanie Mathieson have no conflicts of interest that are directly relevant to the content of this article. Andrew J. McLachlan has provided education services sponsored by Bayer and Haleon. The Sydney Pharmacy School receives research funding from GSK for a scholarship supervised by Andrew J. McLachlan. Manuela L. Ferreira and Andrew J. McLachlan serve on an advisory board for Viatris related to celecoxib use in primary care.
: Not applicable.
: Not applicable.
: Not applicable.
: Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.
: Not applicable.
: SM conceived the review and conducted the search. ZC, KH, HL, SI and SM extracted data. SM and ZC conducted the analyses. All authors contributed to the interpretation of the results. SM drafted the manuscript. All authors contributed and approved the final manuscript.